Autolus Therapeutics plc

AUTL - CIK 0001730463

Market cap-

Rank-

SEC filings305

AUTL balance sheet (annual)

The table below shows Autolus Therapeutics plc's balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.

Line item	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Cash & equivalents	$104.13M	$227.38M	$239.57M	$382.44M	-	-
Short-term investments	-	-	-	-	-	-
Receivables	$24.02M	$15.00K	$109.00K	$121.00K	-	-
Inventory	$33.21M	$4.14M	-	-	-	-
Total current assets

Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.